Lista de obras - Markus Dold - Dominio Público Uruguay

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials

artículo científico publicado en 2015

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials

artículo científico publicado en 2012

Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials

artículo científico publicado en 2016

Beeinflussung des Behandlungsergebnisses einer stationären Psychotherapie von Zwangsstörungen durch den Ausprägungsgrad der Instabilität im Therapieverlauf

artículo científico publicado en 2012

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials

artículo científico

Benzodiazepines for schizophrenia

artículo científico publicado en 2012

Carbamazepine for schizophrenia

artículo científico publicado en 2014

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study

scholarly article by Markus Dold et al published August 2017 in Journal of Psychiatric Research

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

artículo científico publicado en 2018

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

artículo científico publicado en 2018

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

artículo científico publicado en 2018

Combining machine-learning algorithms for prediction of antidepressant treatment response

artículo científico publicado en 2020

Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study

artículo científico publicado en 2019

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).

artículo científico publicado en 2018

Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reports

artículo científico publicado en 2013

Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.

artículo científico publicado en 2017

Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trials.

artículo científico publicado en 2015

Dose-response relationship of selective serotonin reuptake inhibitors

artículo científico publicado en 2020

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression

artículo científico publicado en 2017

Effektivität einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsstörungen – eine Metaanalyse doppelblinder, randomisierter, placebokontrollierter Studien

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.

artículo científico publicado en 2014

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

artículo científico publicado en 2016

Evidence-based pharmacotherapy of treatment-resistant unipolar depression

artículo científico publicado en 2016

Factors contributing to the increasing placebo response in antidepressant trials.

artículo científico publicado en 2015

Flupenthixol versus low-potency first generation antipsychotic drugs for schizophrenia

artículo científico publicado en 2011

Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia

artículo científico publicado en 2014

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

artículo científico publicado en 2018

Haloperidol versus first generation antipsychotics for schizophrenia

artículo científico publicado en 2012

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders

artículo científico publicado en 2015

Increasing placebo response in antipsychotic trials: a clinical perspective.

artículo científico publicado en 2015

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets

artículo científico publicado en 2018

Lithium for schizophrenia

artículo científico publicado en 2015

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

artículo científico publicado en 2017

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression

scientific article published on 02 May 2019

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

artículo científico publicado en 2018

Neuroimaging the various symptom dimensions of obsessive-compulsive disorder

artículo científico publicado en 2009

PS226. The efficacy of light therapy in the treatment of seasonal affective disorder: A meta-analysis of randomized controlled trials

artículo científico publicado en 2016

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers.

artículo científico publicado en 2016

PS87. An update on prediction of treatment outcome in treatment resistant depression.

artículo científico publicado en 2016

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study

artículo científico publicado en 2016

Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective

artículo científico

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression

scientific article published on 15 January 2019

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

artículo científico publicado en 2012

Rapid antidepressant effect of S-ketamine in schizophrenia

artículo científico publicado en 2018

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

artículo científico publicado en 2017

Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice

artículo científico publicado en 2019

Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.

artículo científico publicado en 2017

Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials

article

The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials

scientific article published on 01 October 2019

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study

artículo científico publicado en 2017

Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia

artículo científico publicado en 2011

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia

artículo científico publicado en 2014

Lista de obras de Markus Dold

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials

Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials

Beeinflussung des Behandlungsergebnisses einer stationären Psychotherapie von Zwangsstörungen durch den Ausprägungsgrad der Instabilität im Therapieverlauf

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials

Benzodiazepines for schizophrenia

Carbamazepine for schizophrenia

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

Combining machine-learning algorithms for prediction of antidepressant treatment response

Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).

Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reports

Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.

Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trials.

Dose-response relationship of selective serotonin reuptake inhibitors

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression

Effektivität einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsstörungen – eine Metaanalyse doppelblinder, randomisierter, placebokontrollierter Studien

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

Evidence-based pharmacotherapy of treatment-resistant unipolar depression

Factors contributing to the increasing placebo response in antidepressant trials.

Flupenthixol versus low-potency first generation antipsychotic drugs for schizophrenia

Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

Haloperidol versus first generation antipsychotics for schizophrenia

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders

Increasing placebo response in antipsychotic trials: a clinical perspective.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets

Lithium for schizophrenia

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

Neuroimaging the various symptom dimensions of obsessive-compulsive disorder

PS226. The efficacy of light therapy in the treatment of seasonal affective disorder: A meta-analysis of randomized controlled trials

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers.

PS87. An update on prediction of treatment outcome in treatment resistant depression.

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study

Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

Rapid antidepressant effect of S-ketamine in schizophrenia

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice

Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.

Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials

The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study

Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia